TGTX logo

TG Therapeutics, Inc. (TGTX) Free Cash Flow

Annual FCF:

-$40.56M-$9.15M(-29.12%)
December 31, 2024

Summary

  • As of today, TGTX annual free cash flow is -$40.56 million, with the most recent change of -$9.15 million (-29.12%) on December 31, 2024.
  • During the last 3 years, TGTX annual free cash flow has risen by +$255.47 million (+86.30%).
  • TGTX annual free cash flow is now -46738.34% below its all-time high of -$86.60 thousand, reached on December 31, 2011.

Performance

TGTX Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXcash flow metrics

Quarterly FCF:

$7.39M+$36.13M(+125.73%)
June 30, 2025

Summary

  • As of today, TGTX quarterly free cash flow is $7.39 million, with the most recent change of +$36.13 million (+125.73%) on June 30, 2025.
  • Over the past year, TGTX quarterly free cash flow has increased by +$1.86 million (+33.56%).
  • TGTX quarterly free cash flow is now -91.17% below its all-time high of $83.70 million, reached on September 30, 2023.

Performance

TGTX Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXcash flow metrics

TTM FCF:

-$59.24M+$1.86M(+3.04%)
June 30, 2025

Summary

  • As of today, TGTX TTM free cash flow is -$59.24 million, with the most recent change of +$1.86 million (+3.04%) on June 30, 2025.
  • Over the past year, TGTX TTM free cash flow has dropped by -$127.06 million (-187.34%).
  • TGTX TTM free cash flow is now -187.34% below its all-time high of $67.82 million, reached on June 30, 2024.

Performance

TGTX TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

TGTX Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-29.1%+33.6%-187.3%
3Y3 Years+86.3%+115.0%+78.2%
5Y5 Years+69.5%+116.8%+69.3%

TGTX Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-29.1%+86.3%-91.2%+112.3%-187.3%+75.3%
5Y5-Year-29.1%+86.3%-91.2%+108.5%-187.3%+80.0%
All-TimeAll-Time>-9999.0%+86.3%-91.2%+108.5%-187.3%+80.0%

TGTX Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$7.39M(+125.7%)
-$59.24M(+3.0%)
Mar 2025
-
-$28.74M(-12.0%)
-$61.09M(-50.6%)
Dec 2024
-$40.56M(-29.1%)
-$25.66M(-109.8%)
-$40.56M(-44.3%)
Sep 2024
-
-$12.23M(-320.9%)
-$28.11M(-141.4%)
Jun 2024
-
$5.54M(+167.5%)
$67.82M(+234.4%)
Mar 2024
-
-$8.21M(+37.9%)
$20.28M(+164.6%)
Dec 2023
-$31.41M(+82.2%)
-$13.21M(-115.8%)
-$31.41M(+25.3%)
Sep 2023
-
$83.70M(+299.3%)
-$42.08M(+73.7%)
Jun 2023
-
-$42.01M(+29.9%)
-$160.28M(+4.2%)
Mar 2023
-
-$59.90M(-150.9%)
-$167.39M(+5.0%)
Dec 2022
-$176.18M(+40.5%)
-$23.87M(+30.8%)
-$176.18M(+26.4%)
Sep 2022
-
-$34.50M(+29.8%)
-$239.30M(+12.0%)
Jun 2022
-
-$49.12M(+28.5%)
-$272.08M(+4.0%)
Mar 2022
-
-$68.70M(+21.0%)
-$283.31M(+4.3%)
Dec 2021
-$296.04M(-37.8%)
-$86.99M(-29.3%)
-$296.04M(-13.3%)
Sep 2021
-
-$67.28M(-11.5%)
-$261.23M(-4.3%)
Jun 2021
-
-$60.34M(+25.9%)
-$250.57M(-7.0%)
Mar 2021
-
-$81.42M(-56.0%)
-$234.10M(-9.0%)
Dec 2020
-$214.86M(-61.6%)
-$52.18M(+7.8%)
-$214.86M(-11.3%)
Sep 2020
-
-$56.62M(-29.0%)
-$193.11M(-13.8%)
Jun 2020
-
-$43.88M(+29.4%)
-$169.76M(-4.9%)
Mar 2020
-
-$62.18M(-104.4%)
-$161.75M(-21.7%)
Dec 2019
-$132.94M(-3.0%)
-$30.43M(+8.5%)
-$132.94M(+2.4%)
Sep 2019
-
-$33.27M(+7.3%)
-$136.21M(-0.2%)
Jun 2019
-
-$35.88M(-7.5%)
-$135.97M(-1.2%)
Mar 2019
-
-$33.37M(+1.0%)
-$134.31M(-4.1%)
Dec 2018
-$129.01M(-37.6%)
-$33.70M(-2.0%)
-$129.01M(-10.1%)
Sep 2018
-
-$33.03M(+3.5%)
-$117.17M(-9.6%)
Jun 2018
-
-$34.22M(-21.9%)
-$106.91M(-7.4%)
Mar 2018
-
-$28.07M(-28.4%)
-$99.53M(-6.1%)
Dec 2017
-$93.76M(-51.4%)
-$21.85M(+4.0%)
-$93.76M(-5.4%)
Sep 2017
-
-$22.78M(+15.1%)
-$88.95M(-9.5%)
Jun 2017
-
-$26.83M(-20.3%)
-$81.23M(-20.7%)
Mar 2017
-
-$22.30M(-30.8%)
-$67.28M(-8.6%)
Dec 2016
-$61.93M(-38.4%)
-$17.05M(-13.2%)
-$61.93M(-7.2%)
Sep 2016
-
-$15.05M(-16.9%)
-$57.77M(-8.2%)
Jun 2016
-
-$12.88M(+24.0%)
-$53.41M(-1.2%)
Mar 2016
-
-$16.95M(-31.6%)
-$52.79M(-18.0%)
Dec 2015
-$44.73M(-27.5%)
-$12.88M(-20.4%)
-$44.73M(+4.8%)
Sep 2015
-
-$10.70M(+12.8%)
-$46.97M(-6.0%)
Jun 2015
-
-$12.26M(-37.9%)
-$44.32M(-24.4%)
Mar 2015
-
-$8.89M(+41.2%)
-$35.64M(-1.6%)
Dec 2014
-$35.08M(-226.5%)
-$15.12M(-87.8%)
-$35.08M(-41.1%)
Sep 2014
-
-$8.05M(-125.4%)
-$24.87M(-38.4%)
Jun 2014
-
-$3.57M(+57.1%)
-$17.97M(-6.0%)
Mar 2014
-
-$8.33M(-69.6%)
-$16.96M(-56.6%)
Dec 2013
-$10.74M(-107.1%)
-$4.91M(-325.0%)
-$10.83M(-60.4%)
Sep 2013
-
-$1.16M(+54.8%)
-$6.75M(+21.4%)
Jun 2013
-
-$2.56M(-16.0%)
-$8.59M(-31.5%)
Mar 2013
-
-$2.20M(-164.6%)
-$6.53M(-25.9%)
Dec 2012
-$5.19M(-5892.4%)
-$833.30K(+72.2%)
-$5.19M(-21.4%)
Sep 2012
-
-$2.99M(-497.2%)
-$4.28M(-173.6%)
Jun 2012
-
-$501.20K(+41.8%)
-$1.56M(-34.7%)
Mar 2012
-
-$861.60K(-1179.7%)
-$1.16M(-1240.4%)
Dec 2011
-$86.60K
$79.80K(+128.5%)
-$86.60K(+87.8%)
Sep 2011
-
-$280.20K(-183.6%)
-$708.10K(+15.8%)
Jun 2011
-
-$98.80K(-146.5%)
-$840.60K(+27.2%)
DateAnnualQuarterlyTTM
Mar 2011
-
$212.60K(+139.2%)
-$1.16M(+41.4%)
Dec 2010
-$1.97M(-87.9%)
-$541.70K(-31.3%)
-$1.97M(-12.2%)
Sep 2010
-
-$412.70K(+0.2%)
-$1.76M(-18.3%)
Jun 2010
-
-$413.60K(+31.6%)
-$1.49M(-47.4%)
Mar 2010
-
-$604.80K(-84.9%)
-$1.01M(+3.9%)
Dec 2009
-$1.05M(+76.4%)
-$327.10K(-132.2%)
-$1.05M(+36.1%)
Sep 2009
-
-$140.90K(-319.8%)
-$1.64M(+22.6%)
Jun 2009
-
$64.10K(+109.9%)
-$2.12M(+41.7%)
Mar 2009
-
-$645.80K(+29.8%)
-$3.64M(+18.3%)
Dec 2008
-$4.45M(+56.5%)
-$919.80K(-48.3%)
-$4.45M(+9.4%)
Sep 2008
-
-$620.30K(+57.3%)
-$4.92M(+30.3%)
Jun 2008
-
-$1.45M(+0.7%)
-$7.05M(+25.9%)
Mar 2008
-
-$1.46M(-5.7%)
-$9.51M(+7.1%)
Dec 2007
-$10.24M(-31.5%)
-$1.38M(+49.8%)
-$10.24M(+0.1%)
Sep 2007
-
-$2.76M(+29.6%)
-$10.25M(-6.5%)
Jun 2007
-
-$3.91M(-78.9%)
-$9.62M(-17.5%)
Mar 2007
-
-$2.19M(-57.4%)
-$8.19M(-5.2%)
Dec 2006
-$7.79M(-23.9%)
-$1.39M(+34.8%)
-$7.79M(+8.1%)
Sep 2006
-
-$2.13M(+14.1%)
-$8.48M(-9.1%)
Jun 2006
-
-$2.48M(-39.1%)
-$7.77M(-14.8%)
Mar 2006
-
-$1.78M(+14.2%)
-$6.77M(-7.7%)
Dec 2005
-$6.28M(-7.8%)
-$2.08M(-45.8%)
-$6.28M(-1.2%)
Sep 2005
-
-$1.43M(+3.7%)
-$6.21M(+0.4%)
Jun 2005
-
-$1.48M(-14.1%)
-$6.23M(-7.2%)
Mar 2005
-
-$1.30M(+35.1%)
-$5.81M(+0.3%)
Dec 2004
-$5.83M(-68.6%)
-$2.00M(-38.3%)
-$5.83M(-5.2%)
Sep 2004
-
-$1.45M(-36.1%)
-$5.54M(-20.0%)
Jun 2004
-
-$1.06M(+19.0%)
-$4.62M(-9.4%)
Mar 2004
-
-$1.31M(+23.4%)
-$4.22M(-22.1%)
Dec 2003
-$3.46M(-351.6%)
-$1.72M(-226.9%)
-$3.46M(-72.7%)
Sep 2003
-
-$524.70K(+21.5%)
-$2.00M(-29.4%)
Jun 2003
-
-$668.70K(-21.7%)
-$1.55M(-13.1%)
Mar 2003
-
-$549.40K(-111.6%)
-$1.37M(+4.9%)
Dec 2002
-$765.70K(+83.3%)
-$259.60K(-275.1%)
-$1.44M(+26.9%)
Sep 2002
-
-$69.20K(+85.9%)
-$1.97M(+20.9%)
Jun 2002
-
-$489.50K(+21.0%)
-$2.49M(+9.1%)
Mar 2002
-
-$619.70K(+21.4%)
-$2.74M(+40.3%)
Dec 2001
-$4.58M(-246.0%)
-$788.80K(-33.8%)
-$4.58M(-97.6%)
Sep 2001
-
-$589.40K(+20.4%)
-$2.32M(+5.4%)
Jun 2001
-
-$740.00K(+70.0%)
-$2.45M(+27.1%)
Mar 2001
-
-$2.46M(-267.1%)
-$3.36M(-153.6%)
Dec 2000
-$1.32M(+44.8%)
$1.48M(+304.6%)
-$1.32M(+56.2%)
Sep 2000
-
-$720.90K(+56.3%)
-$3.03M(-10.7%)
Jun 2000
-
-$1.65M(-283.7%)
-$2.73M(-39.1%)
Mar 2000
-
-$429.70K(-89.1%)
-$1.97M(+17.0%)
Dec 1999
-$2.40M(+14.3%)
-$227.20K(+46.8%)
-$2.37M(+29.5%)
Sep 1999
-
-$427.40K(+51.5%)
-$3.36M(+20.9%)
Jun 1999
-
-$880.70K(-5.8%)
-$4.25M(-107.2%)
Mar 1999
-
-$832.80K(+31.6%)
-$2.05M(+25.9%)
Dec 1998
-$2.80M(+34.9%)
-$1.22M(+7.4%)
-$2.77M(-0.6%)
Sep 1998
-
-$1.31M(-199.9%)
-$2.75M(-4.3%)
Jun 1998
-
$1.32M(+184.9%)
-$2.63M(+47.8%)
Mar 1998
-
-$1.55M(-29.1%)
-$5.05M(-17.4%)
Dec 1997
-$4.30M(-4.9%)
-$1.20M(0.0%)
-$4.30M(-38.7%)
Sep 1997
-
-$1.20M(-9.1%)
-$3.10M(-63.2%)
Jun 1997
-
-$1.10M(-37.5%)
-$1.90M(-137.5%)
Mar 1997
-
-$800.00K
-$800.00K
Dec 1996
-$4.10M
-
-

FAQ

  • What is TG Therapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual free cash flow year-on-year change?
  • What is TG Therapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is TG Therapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. TTM free cash flow year-on-year change?

What is TG Therapeutics, Inc. annual free cash flow?

The current annual free cash flow of TGTX is -$40.56M

What is the all-time high annual free cash flow for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual free cash flow is -$86.60K

What is TG Therapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, TGTX annual free cash flow has changed by -$9.15M (-29.12%)

What is TG Therapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of TGTX is $7.39M

What is the all-time high quarterly free cash flow for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly free cash flow is $83.70M

What is TG Therapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, TGTX quarterly free cash flow has changed by +$1.86M (+33.56%)

What is TG Therapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of TGTX is -$59.24M

What is the all-time high TTM free cash flow for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high TTM free cash flow is $67.82M

What is TG Therapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, TGTX TTM free cash flow has changed by -$127.06M (-187.34%)
On this page